高分子量激肽原(HMWK)重組蛋白
Recombinant High Molecular Weight Kininogen (HMWK)
Williams-Fitzgerald-Flaujeac Factor; Fitzgerald Factor; HMWK-Kallikrein Factor
- 編號RPB805Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌, 細胞外基質
- 預測分子量14.3kDa
- 實際分子量15kDa(差異分析請參閱說明書)
- 片段與標簽Arg58~Leu176 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點6.3
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB805Hu01 | 高分子量激肽原(HMWK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB805Hu02 | 高分子量激肽原(HMWK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB805Hu01 | 高分子量激肽原(HMWK)多克隆抗體 | WB; IHC; ICC; IP. |
PAB805Hu02 | 高分子量激肽原(HMWK)多克隆抗體 | WB; IHC; ICC; IP. |
LAB805Hu71 | 高分子量激肽原(HMWK)多克隆抗體(生物素標記) | WB; IHC; ICC. |
SEB805Hu | 高分子量激肽原(HMWK)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB805Hu | 高分子量激肽原(HMWK)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB805Hu | 高分子量激肽原(HMWK)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Thromb Res | Factor XII–mediated contact activation related to poor prognosis in disseminated intravascular coagulation [PubMed: 26706311] |
Thrombosis Research | Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coaCavia (Guinea pig )lation [Pubmed:26706311] |
european journal of endocrinology | Contact system activation and high thrombin generation in hyperthyroidism. [pubmed:28137735] |
J Thromb Thrombolysis | Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors [Pubmed:34993714] |
留言咨詢